Metformin and reduced risk of cancer in diabetic patients - PubMed (original) (raw)

Metformin and reduced risk of cancer in diabetic patients

Josie M M Evans et al. BMJ. 2005.

No abstract available

PubMed Disclaimer

Similar articles

Cited by

References

    1. Hawley SA, Boudeau J, Reid JL, Mustard KJ, Udd L, Makela TP, et al. Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J Biol 2003;2(4): 28. - PMC - PubMed
    1. Lizcano JM, Goransson O, Toth R, Deak M, Morrice NA, Boudeau J, et al. LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. The EMBO Journal 2004;23: 833-43. - PMC - PubMed
    1. Bauman AE. Updating the evidence that physical exercise is good for health: an epidemiologic review. J Sci Med Sport 2004;7: 6-19. - PubMed
    1. Morris AD, Boyle DIR, MacAlpine R, Emslie-Smith A, Jung RT, Newton RW, et al. The diabetes audit and research in Tayside Scotland (DARTS) study: electronic record-linkage to create a diabetes register. BMJ 1997;315: 524-8. - PMC - PubMed
    1. Evans JMM, McMahon AD, McGilchrist MM, White G, Murray FE, McDevitt DG, et al. Topical non-steroidal anti-inflammatory drugs and hospitalisation for upper gastrointestinal bleeding and perforation. BMJ 1995;311: 22-8. - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources